Vitamin D levels in children with autism spectrum disorders and normal children: a comparative cross-sectional study from South Kerala
DOI:
https://doi.org/10.18203/2349-3291.ijcp20260101Keywords:
Autism spectrum disorder, ASD severity, Kerala, Vitamin DAbstract
Background: Epidemiological evidence indicates that vitamin D deficiency during critical periods may increase the risk of neurodevelopmental disorders including autism spectrum disorder. The present study aimed to assess and compare the vitamin D levels of children with autism spectrum disorder (ASD) and neurotypical children and also to explore the relationship between vitamin D status and the severity of ASD symptoms.
Methods: This comparative cross-sectional study was conducted among children with ASD and children without any neuro developmental disorders. About 207 children aged two to six years were enrolled, comprising 105 participants with ASD and 102 who did not have an ASD diagnosis. ASD diagnosis was done using DSM-5 criteria and severity was assessed using CARS-2 ST scale. Serum 25-hydroxyvitamin D levels were obtained for every participant in the study. Statistical analyses included chi-square and independent t-tests, with significance set at p<0.05.
Results: The majority of children in both groups were in the 24–36-month age range. Individuals with ASD showed a higher likelihood of low vitamin D levels (87.6%) relative to non-ASD cases (76.5%); while desirable vitamin D levels were observed more among normal children (23.5%) than children with ASD (12.4%). The association between Vitamin D levels and ASD status was also found to be statistically significant.
Conclusions: Our findings indicate that low vitamin D levels may be linked to ASD, highlighting a potential area for further investigation and suggest that vitamin D could have a supportive role in management.
Metrics
References
Chowdhury S. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed. Washington (DC): American Psychiatric Association Publishing. 2013. DOI: https://doi.org/10.1176/appi.books.9780890425596
World Health Organization. Autism spectrum disorders. 2023. Available at: https://www.who.int/news-room/fact-sheets/detail/autism-spectrum-disorders. Accessed on 21 August 2025.
Abrahams BS, Geschwind DH. Advances in autism genetics: on the threshold of a new neurobiology. Nat Rev Genet. 2008;9:341–55. DOI: https://doi.org/10.1038/nrg2346
Hisle-Gorman E, Susi A, Stokes T, Gorman G, Erdie-Lalena C, Nylund CM. Prenatal, perinatal and neonatal risk factors of autism spectrum disorder. Pediatr Res. 2018;84:190–8. DOI: https://doi.org/10.1038/pr.2018.23
Cannell JJ. Vitamin D and autism, what’s new. Rev Endocr Metab Disord. 2017;18:183–93. DOI: https://doi.org/10.1007/s11154-017-9409-0
Lee BK, Eyles DW, Magnusson C, Newschaffer CJ, McGrath JJ, Kvaskoff D, et al. Developmental vitamin D and autism spectrum disorders: findings from the Stockholm Youth Cohort. Mol Psychiatry. 2019;26:1578–88. DOI: https://doi.org/10.1038/s41380-019-0578-y
Grant WB, Cannell JJ. Autism prevalence in the United States with respect to solar UV-B doses: an ecological study. Dermatoendocrinol. 2013;5(1):159–64. DOI: https://doi.org/10.4161/derm.22942
DeLuca GC, Kimball SM, Kolasinski J. Review: the role of vitamin D in nervous system health and disease. Neuropathol Appl Neurobiol. 2013;39(5):458–84. DOI: https://doi.org/10.1111/nan.12020
Cannell JJ, Grant WB. What is the role of vitamin D in autism? Dermatoendocrinol. 2013;5(1):199–204. DOI: https://doi.org/10.4161/derm.24356
Smaga I, Niedzielska E, Gawlik M, Moniczewski A, Krzek J, Przegaliński E, et al. Oxidative stress as an etiological factor and a potential treatment target of psychiatric disorders. Part 2. Depression, anxiety, schizophrenia and autism. Pharmacol Rep. 2015;67(3):569–80. DOI: https://doi.org/10.1016/j.pharep.2014.12.015
Cortelazzo A, De Felice C, Guerranti R, Signorini C, Leoncini S, Zollo G, et al. Expression and oxidative modifications of plasma proteins in autism spectrum disorders: interplay between inflammatory response and lipid peroxidation. Proteomics Clin Appl. 2016;10(11):1103–12. DOI: https://doi.org/10.1002/prca.201500076
Gatti D, Idolazzi L, Fassio A. Vitamin D: not just bone, but also immunity. Minerva Med.2016;107(6):452–60.
Krakowiak P, Goines PE, Tancredi DJ, Ashwood P, Hertz-Picciotto I, Hansen RL, et al. Neonatal cytokine profiles associated with autism spectrum disorder. Biol Psychiatry. 2015.
Wang T, Shan L, Du L, Feng J, Xu Z, Staal WG, Jia F. Serum concentration of 25-hydroxyvitamin D in autism spectrum disorder: a systematic review and meta-analysis. Eur Child Adolesc Psychiatry. 2016;25(4):341–50. DOI: https://doi.org/10.1007/s00787-015-0786-1
Coşkun S, Şimşek Ş, Camkurt MA, Çim A, Çelik SB. Association of polymorphisms in the vitamin D receptor gene and serum 25-hydroxyvitamin D levels in children with autism spectrum disorder. Gene. 2016;588(2):109–14. DOI: https://doi.org/10.1016/j.gene.2016.05.004
Schmidt RJ, Hansen RL, Hartiala J, Allayee H, Sconberg JL, Schmidt LC, et al. Selected vitamin D metabolic gene variants and risk for autism spectrum disorder in the study. Early Hum Dev. 2015;91(8):483–9. DOI: https://doi.org/10.1016/j.earlhumdev.2015.05.008
Kočovská E, Fernell E, Billstedt E. Vitamin D and autism: clinical review. Res Dev Disabil. 2012;33(5):1541–50. DOI: https://doi.org/10.1016/j.ridd.2012.02.015
Bener A, Khattab AO, Bhugra D, Hoffmann GF. Iron and vitamin D levels among autism spectrum disorders children. Ann Afr Med. 2017;16(4):186–91. DOI: https://doi.org/10.4103/aam.aam_17_17
Vaughan CA. Test review: Schopler E, Van Bourgondien ME, Wellman GJ, Love SR. Childhood Autism Rating Scale (2nd ed.). Los Angeles (CA): Western Psychological Services; 2010. J Psychoeduc Assess. 2011;29(5):489–93. DOI: https://doi.org/10.1177/0734282911400873
Corsello A, Spolidoro GCI, Milani GP, Agostoni C. Vitamin D in pediatric age: current evidence, recommendations and misunderstandings. Front Med (Lausanne). 2023;10:1107855. DOI: https://doi.org/10.3389/fmed.2023.1107855
Mostafa GA, Al-Ayadhi LY. Reduced serum concentrations of 25-hydroxy vitamin D in children with autism: relation to autoimmunity. J Neuroinflammation. 2012;9:201. DOI: https://doi.org/10.1186/1742-2094-9-201
Saad K, Abdel-Rahman AA, Elserogy YM, Al-Atram AA, Cannell JJ, Bjørklund G, et al. Vitamin D status in autism spectrum disorders and the efficacy of vitamin D supplementation in autistic children. Nutr Neurosci. 2016;19(8):346–51. DOI: https://doi.org/10.1179/1476830515Y.0000000019
Song L, Luo X, Jiang Q, Chen Z, Zhou L, Wang D, et al. Vitamin D supplementation is beneficial for children with autism spectrum disorder: a meta-analysis. Clin Psychopharmacol Neurosci. 2020;18(2):203–13. DOI: https://doi.org/10.9758/cpn.2020.18.2.203
Wang J, Huang H, Liu C, Zhang Y, Wang W, Zou Z, et al. Research progress on the role of vitamin D in autism spectrum disorder. Front Behav Neurosci. 2022;16:859151. DOI: https://doi.org/10.3389/fnbeh.2022.859151
Fahmy F, Sabri N, El Hamamsy M, El Sawi M, Zaki O. Vitamin D intake and sun exposure in autistic children. Int J Pharm Sci Res. 2016;7:1043–9.
Basheer S, Natarajan A, van Amelsvoort T, Venkataswamy MM, Ravi V, Srinath S, et al. Vitamin D status of children with autism spectrum disorder: case-control study from India. Asian J Psychiatry. 2017;30:200–1. DOI: https://doi.org/10.1016/j.ajp.2017.10.031
Altun H, Kurutaş EB, Şahin N, Güngör O, Fındıklı E. The levels of vitamin D, vitamin D receptor, homocysteine and complex B vitamin in children with autism spectrum disorders. Clin Psychopharmacol Neurosci. 2018;16:383–90. DOI: https://doi.org/10.9758/cpn.2018.16.4.383
Mansour A, Amer A, Sobh A. Vitamin D profile in autism spectrum disorder children and its relation to the disease severity. Egypt J Otolaryngol. 2024;40:7. DOI: https://doi.org/10.1186/s43163-024-00573-w
Jia F, Wang B, Shan L, Xu Z, Staal WG, Du L. Core symptoms of autism improved after vitamin D supplementation. Pediatrics. 2015;135(1):196–8. DOI: https://doi.org/10.1542/peds.2014-2121
Downloads
Published
How to Cite
Issue
Section
